Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Apr 3;2(2):yty038.
doi: 10.1093/ehjcr/yty038. eCollection 2018 Jun.

Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report

Affiliations
Case Reports

Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report

Gerard Oristrell et al. Eur Heart J Case Rep. .

Abstract

Introduction: Patients who receive or have received anti-programmed cell-death-1 (PD-1) monoclonal antibodies can develop immune-related adverse events due to activation of the immune system.

Case presentation: We report a case of a patient who received pembrolizumab and presented with cardiac tamponade. Despite pericardial drainage, she persisted with refractory arterial hypotension due to secondary adrenal insufficiency. After initiating corticosteroid therapy, the patient recovered successfully.

Discussion: The association of pericarditis, hypophysitis and thyroid dysfunction support the diagnosis of a life-threatening immune-related adverse event due to pembrolizumab. In case of immune-related adverse events secondary to anti-PD-1 monoclonal antibodies, corticosteroid therapy should be promptly initiated in order to avoid major complications.

Keywords: Adrenal insufficiency; Cardiac tamponade; Case report; Corticosteroids; Pembrolizumab; Pericarditis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Pulsed Doppler recording of left ventricular inflow showing reduced early diastolic filling with inspiration. (B) Pulsed Doppler recording of pulmonary vein flow showing a prominent diastolic filling phase. (C) Subcostal view showing a dilated inferior vena cava reflecting the elevated right atrial pressure. (D) Pulsed Doppler recording of hepatic vein flow showing increased hepatic vein flow reversal with expiration.
Figure 2
Figure 2
(A) Acute pericarditis, haematoxylin, and eosin staining. (B) CD3+ infiltrated in the pericardium. (C, D) Huge infiltration in pericardium with predominance of neutrophils, although there are some lymphocytes.
Figure 3
Figure 3
(A) Four-chamber and (B) two-chamber end-diastole cine-RM images show a thickened pericardium without pericardial effusion (arrows). Note mild bilateral pleural effusion (asterisks). (C) Four-chamber short-tau inversion recovery (STIR) T2-weighted imaging shows diffuse pericardial hyperintensity suggesting pericardial oedema (arrows) and (D) two-chamber delayed-contrast-enhanced imaging depicts diffuse pericardial enhancement (arrows) indicating pericardial inflammation.

References

    1. Imazio M, Gaita F.. Diagnosis and treatment of pericarditis. Heart 2015;101:1159–1168. - PubMed
    1. Wang DY, Okoye GD, Neilan TG, Johnson DB, Moslehi JJ.. Cardiovascular toxicities associated with cancer immunotherapies. Curr Cardiol Rep 2017;19:21.. - PMC - PubMed
    1. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM.. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016;37:2768–2801. - PubMed
    1. Gentry J, Klein AL, Jellis CL.. Transient constrictive pericarditis: current diagnostic and therapeutic strategies. Curr Cardiol Rep 2016;18:41.. - PubMed
    1. Byun DJ, Wolchok JD, Rosenberg LM, Girotra M.. Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol 2017;13:195–207. - PMC - PubMed

Publication types

LinkOut - more resources